Sanofi and Novartis settle patent litigation over gene-0therapy drug
MLex Summary: A US patent litigation between Sanofi's subsidiary Genzyme and Novartis Gene Therapies, Novartis Pharmaceutical, and Novartis AG has beem settled. Biopharmaceutical company MediciNova, which is entitled to receive damages...To view the full article, register now.
Already a subscriber? Click here to view full article